Where should you be in November 2012?

antibodies, nascent biologic, merrimack, INSERM, Hoffmann-La Roche

What major benefits do you expect delegates will gain from attending the European Antibody Congress?

In a recent interview in association with the European Antibody Congress, we posed this question to 4 of our top speakers, and here is what they had to say:

"The major benefits delegates will gain from attending the European Antibody Congress consist of overview updates on research, applications, production, and clinical issues in antibody science. More importantly, these updates will be from European leaders that will provide a European viewpoint on a global market." Mark Glassy, CEO, Nascent Biologics

"In my experience EAC provides excellent networking opportunities and gives a solid overview of the recent development and trends in antibody therapeutics. " Alexey Lugovskoy, Senior Director of Therapeutic Design, Merrimack Pharmaceuticals

"State of the art knowledge on Mab technology and development as well as precious networking." Charles Dumontet, Co-Director, INSERM

"They see what others are doing and what is state of the art." Dietmar Reusch, Director Development Characterisation, Hoffmann-La Roche

DOWNLOAD the complete interviews and gain all the facts!

Want to find out more? Learn about :

New format European Antibody Congress 2012

Antibody development in the next 5 years

Antibodies: Top pre-clinical and clinical ADC programs from Pfizer

If you want to find out more then you need to attend the 8th annual European Antibody CongressDOWNLOAD the brochure for the complete agenda.

Leave a Reply

Your email address will not be published. Required fields are marked *